PROFITELLIGENCE/Guest access
!
Financial disclaimer

Profitelligence provides financial data and analytics for informational purposes only. Nothing on this platform constitutes investment advice, a recommendation, or an offer to buy or sell any securities. Past performance does not guarantee future results. Always do your own research and consult a licensed financial advisor before making investment decisions.

Legal agreement

By continuing, you acknowledge that you have read and agree to our Terms of Service and Privacy Policy.

i
Guest mode

You're browsing as a guest. Some features like watchlists and alerts require a free account.

--:--:--
Guest mode— viewing CNC. Sign up free to access all symbols.Sign up
CNC logo

CNC

Centene Corporation

HealthcareHealthcare Plans

Price performance

Sep 18, 2026
$65.11
$1.99-2.97%
1M
+0.63%
3M
+6.70%
YTD
+55.84%
vs SPY
+1.63%
30d range
62–70
Volatility
34.41%
Signals
Price chart

Company activity

44 events
Company activity
TimeTickerTypeEventQtyPriceValue
5dCNC8-KCentene Corporation to Discuss Financial Guidance at Deutsche Bank 2026 Healthcare Summit
08/17CNC8-KCentene Appoints New CFO Chris Neczypor
07/29CNC8-KCentene Corporation Announces Partial Redemption of 4.25% Notes Due 2027
07/27CNC8-KCentene Reports Q2 2026 Financial Results and Board Changes
06/22CNC8-KCentene Appoints Lauren M. Tyler to Board of Directors
05/15CNC8-KCentene Corporation Annual Meeting Results and Executive Appointments
04/27CNC8-KCentene Corporation Reports Strong Q1 2026 Results and Updates Guidance
03/24CNC8-KCentene Appoints New Chief Accounting Officer
03/09CNC8-KCentene Announces Redemption of $1 Billion in 2027 Notes
02/20CNC8-KCentene Reaffirms 2026 Earnings Guidance
02/05CNC8-KCentene Reports 2025 Results and Provides 2026 Guidance
11/10/25CNC8-KCentene to Discuss Financial Outlook at UBS 2025 Global Healthcare Conference
10/28/25CNC8-KCentene Reports Q3 2025 Financial Results
09/10/25CNC8-KCentene Corporation to Discuss Financial Results at Deutsche Bank Healthcare Summit
08/15/25CNC8-KBoard Member Thomas R. Greco Resigns from Centene Corporation
08/04/25CNC8-KImmediate Resignation of Director Wayne S. DeVeydt from Centene Corporation
07/25/25CNC8-KCentene Corporation Reports Second Quarter 2025 Financial Results
07/01/25CNC8-KCentene Corporation Withdraws 2025 Earnings Guidance
05/14/25CNC8-KCentene Corporation Holds Annual Meeting and Votes on Key Proposals
05/06/25CNC8-KCentene Corporation Reaffirms 2025 Earnings Guidance
04/25/25CNC8-KCentene Reports Strong Q1 2025 Earnings and Raises Guidance
03/12/25CNC8-KCentene Reaffirms 2025 Earnings Guidance at Barclays Conference
03/05/25CNC8-KCentene Corporation Enters into New Credit Agreement
03/03/25CNC8-KCentene Corporation Reaffirms 2025 EPS Guidance
02/24/25CNC8-KCentene Appoints Kenneth Y. Tanji to Board of Directors
02/04/25CNC8-KCentene Reports 2024 Financial Results and Membership Growth
12/12/24CNC8-KCentene Corporation Reaffirms 2024 Guidance and Provides 2025 Financial Outlook
11/13/24CNC8-KCentene Corporation Announces Investor Meeting and Reaffirms 2024 Earnings Guidance
11/12/24CNC8-KKenneth J. Fasola to Retire as President of Centene Corporation
10/25/24CNC8-KCentene Reports Q3 2024 Financial Results
10/11/24CNC8-KCentene Announces Improvement in Medicare Advantage Star Ratings
10/03/24CNC8-KBoard Committee Appointments for New Director
09/27/24CNC8-KCentene Corporation Announces Departure of Director Lori J. Robinson
09/16/24CNC8-KCentene Corporation to Reaffirm 2024 Earnings Guidance at Upcoming Investor Meetings
09/10/24CNC8-KCentene Reaffirms 2024 EPS Guidance and Shifts Q4 Performance
08/15/24CNC8-KCentene Appoints Thomas Greco to Board of Directors
07/26/24CNC8-KCentene Corporation Reports Second Quarter 2024 Results
07/23/24CNC8-KCentene Announces Preliminary Q2 2024 Financial Results
05/29/24CNC8-KCentene Reaffirms 2024 Guidance and Discloses Conference Presentation Details
05/16/24CNC8-KCentene Corporation Annual Meeting Voting Results
04/26/24CNC8-KCentene Corporation Announces Q1 2024 Results and Raises Guidance
03/29/24CNC8-KJames E. Murray Retires from Centene Corporation
03/11/24CNC8-KCentene Corporation to Reaffirm 2024 Earnings Guidance at Barclays Healthcare Conference
02/06/24CNC8-KCentene Reports 2023 Earnings with Adjusted EPS of $6.68

CNC filing record

Centene Corporation (CNC): 44 8-K filings summarized, the most recent on Sep 15, 2026.

What the 8-K filings said

  1. Sep 15, 2026 · low impact

    Centene Corporation announced its participation in the Deutsche Bank 2026 Healthcare Summit on September 16, 2026, where management will discuss the company's business and financial results. The company reaffirmed its full-year 2026 GAAP diluted earnings per share (EPS) guidance of greater than $3.11 and its full-year…

    Centene Corporation to Discuss Financial Guidance at Deutsche Bank 2026 Healthcare Summit
  2. Aug 17, 2026 · high impact

    Centene Corporation announced that its current Chief Financial Officer (CFO), Andrew Asher, will retire at the end of 2027 after stepping down from his CFO role on December 31, 2026. Chris Neczypor, previously CFO of Lincoln National Corporation, will succeed Asher as Centene's CFO, effective January 1, 2027. Neczypor…

    Centene Appoints New CFO Chris Neczypor
  3. Jul 29, 2026 · medium impact

    On July 29, 2026, Centene Corporation announced the partial redemption of $500,000,000 aggregate principal amount of its outstanding 4.25% Notes due December 15, 2027. The redemption is scheduled for August 13, 2026, and will leave approximately $568,664,000 of the 2027 Notes outstanding. The redemption price includes…

    Centene Corporation Announces Partial Redemption of 4.25% Notes Due 2027
  4. Jul 27, 2026 · medium impact

    Centene Corporation announced its financial results for the second quarter of 2026, reporting GAAP diluted earnings per share of $2.19 and adjusted diluted earnings per share of $2.51. The company also increased its full-year 2026 guidance for GAAP diluted EPS to greater than $3.11 and for adjusted diluted EPS to…

    Centene Reports Q2 2026 Financial Results and Board Changes
  5. Jun 22, 2026 · high impact

    Centene Corporation announced the appointment of Lauren M. Tyler to its Board of Directors, effective June 19, 2026. Ms. Tyler, with over 30 years of leadership experience in various sectors, will serve on the Audit Committee and the Compensation and Talent Committee. Her extensive background includes senior roles at…

    Centene Appoints Lauren M. Tyler to Board of Directors

SEC filings in the last five years

  • 71 Form 8-K
  • 13 Form 10-Q
  • 5 Form 10-K
  • 2 Form 8-K/A